HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
PODD
Insulet Corporation
PODD's fundamentals are strong and it looks cheap: trading at 24x earnings, less than half its usual 148x. Analysts expect strong earnings growth, though they disagree widely on how much.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
PODD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
PODD's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
PODD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 20x | $149 | — |
| Current | 24x | $149 | — |
| Cheap | 45x | $277 | +86% |
| Fair | 136x | $835 | +459% |
| Expensive | 1,179x | $7,213 | +4732% |
Historical ranges are pointers, not guarantees.
PODD's PE is in its cheap range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
PODD Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
PODD has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
PODD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.52 | +23% |
| Q3 2026 | $6.12 | +78% |
| Q2 2026 | $5.33 | +63% |
| Q1 2026 | $4.28 | -23% |
| Q4 2025 | $3.48 | -40% |
| Q3 2025 | $3.44 | -41% |
| Q2 2025 | $3.28 | -41% |
| Q1 2025 | $5.55 | +67% |
| Q4 2024 | $5.78 | +97% |
PODD has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over PODD on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
PODD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $842M | +19% |
| Q2 2026 | $801.7M | +24% |
| Q1 2026 | $761.7M | +34% |
| Q4 2025 | $783.8M | +31% |
| Q3 2025 | $706.3M | +30% |
| Q2 2025 | $649.1M | +33% |
| Q1 2025 | $569M | +29% |
| Q4 2024 | $597.5M | +17% |
PODD's revenue has grown year over year every quarter since late 2020: $842M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +5.9 points |
| Q2 2026 | 16% | -2.5 points |
| Q1 2026 | 16% | +0.4 points |
| Q4 2025 | 19% | +0.4 points |
| Q3 2025 | 17% | +0.5 points |
| Q2 2025 | 19% | +7.5 points |
| Q1 2025 | 16% | +2.7 points |
| Q4 2024 | 18% | -2.6 points |
PODD has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over PODD on cash flow, with more consistent year-over-year improvement.
PODD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $66.4M | -34% |
| Q2 2026 | $55.9M | -69% |
| Q1 2026 | $89.5M | +74% |
| Q4 2025 | $48.2M | -49% |
| Q3 2025 | $100.1M | +39% |
| Q2 2025 | $177.9M | +140% |
| Q1 2025 | $51.5M | -21% |
| Q4 2024 | $94.1M | +492% |
PODD still generates free cash flow, though less than at its 2025 peak: $260M over the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over PODD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
PODD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +89K shares |
| 1 year | -1.7% | -1.2M shares |
| 3 years | -5.6% | -4.1M shares |
| 5 years | -0.2% | -127K shares |
| Available history | +12% | +7.2M shares |
PODD has 69M diluted shares, down 1.7% from a year ago, with $300M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $300M |
| Q4 2025 | — |
| Q3 2025 | $29.5M |
PODD spent $300M buying back its own shares over the past year.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
PODD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | 0.4x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.6x | Very low |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 1.1x | Healthy |
PODD's net debt is less than a year of its operating earnings (EBITDA).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
PODD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.0 | Neutral |
| Stochastic | 48.9 | Neutral |
PODD's weekly RSI is 44 (neutral) and its Stochastic is 49 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
PODD PE vs Healthcare Sector
| Metric | PODD | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 26x | 5.6% below |
| PE % | 0 | 29 | 29 pts below |
PODD is trading at 24x earnings, in line with the Healthcare sector's median of 26x.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
PODD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $142.3 | 4.9% above |
| 20 week MA | $147.8 | 1% above |
| 50 week MA | $191.3 | 22% below |
| 100 week MA | $243.7 | 39% below |
| 200 week MA | $234.4 | 36% below |
PODD has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over PODD on returns for 2026, with the stronger performance.
PODD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $172.5 | $257.3 | +49% |
| 2021 | $257.3 | $273.3 | +6.2% |
| 2022 | $273.3 | $292.1 | +6.9% |
| 2023 | $292.1 | $217.0 | -26% |
| 2024 | $217.0 | $265.1 | +22% |
| 2025 | $265.1 | $288.6 | +8.9% |
| 2026 YTD | $288.6 | $149.3 | -48% |
PODD is down 48% so far in 2026, after finishing higher in five of the previous six years.